Design, synthesis, and evaluation of substituted phenylpropanoic acid derivatives as human peroxisome proliferator activated receptor activators. Discovery of potent and human peroxisome proliferator activated receptor α subtype-selective activators

Masahiro Nomura, Takahiro Tanase, Tomohiro Ide, Masaki Tsunoda, Masahiro Suzuki, Hideharu Uchiki, Koji Murakami, Hiroyuki Miyachi

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Substituted phenylpropanoic acid derivatives were prepared as part of a search for subtype-selective human peroxisome proliferator activated receptor α (PPARα) activators. Structure-activity relationship studies indicated that the nature and the stereochemistry of the substituent at the α-position of the head part containing the carboxyl group, the distance between the carboxyl group and the central benzene ring, the linking group between the central benzene ring and the distal benzene ring, and the substituent at the distal hydrophobic tail part of the molecule all play key roles in determining the potency and selectivity of PPAR subtype transactivation. This study has led to the identification of potent and human PPARα selective optically active α-alkylphenylpropanoic acid derivatives, which will be useful not only as pharmacological tools to investigate the physiology and pathophysiology of PPARα but also as candidate drugs for the treatment of altered metabolic homeostasis, such as dyslipidemia, obesity, and diabetes.

Original languageEnglish
Pages (from-to)3581-3599
Number of pages19
JournalJournal of Medicinal Chemistry
Volume46
Issue number17
DOIs
Publication statusPublished - Aug 14 2003
Externally publishedYes

Fingerprint

Peroxisome Proliferator-Activated Receptors
Benzene
Derivatives
Acids
Forensic Anthropology
Stereochemistry
Physiology
Structure-Activity Relationship
Medical problems
Dyslipidemias
Transcriptional Activation
Tail
Homeostasis
Obesity
Head
Pharmacology
Molecules
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Design, synthesis, and evaluation of substituted phenylpropanoic acid derivatives as human peroxisome proliferator activated receptor activators. Discovery of potent and human peroxisome proliferator activated receptor α subtype-selective activators. / Nomura, Masahiro; Tanase, Takahiro; Ide, Tomohiro; Tsunoda, Masaki; Suzuki, Masahiro; Uchiki, Hideharu; Murakami, Koji; Miyachi, Hiroyuki.

In: Journal of Medicinal Chemistry, Vol. 46, No. 17, 14.08.2003, p. 3581-3599.

Research output: Contribution to journalArticle

Nomura, Masahiro ; Tanase, Takahiro ; Ide, Tomohiro ; Tsunoda, Masaki ; Suzuki, Masahiro ; Uchiki, Hideharu ; Murakami, Koji ; Miyachi, Hiroyuki. / Design, synthesis, and evaluation of substituted phenylpropanoic acid derivatives as human peroxisome proliferator activated receptor activators. Discovery of potent and human peroxisome proliferator activated receptor α subtype-selective activators. In: Journal of Medicinal Chemistry. 2003 ; Vol. 46, No. 17. pp. 3581-3599.
@article{d1dc6b0175be4e2db53166940d91ea89,
title = "Design, synthesis, and evaluation of substituted phenylpropanoic acid derivatives as human peroxisome proliferator activated receptor activators. Discovery of potent and human peroxisome proliferator activated receptor α subtype-selective activators",
abstract = "Substituted phenylpropanoic acid derivatives were prepared as part of a search for subtype-selective human peroxisome proliferator activated receptor α (PPARα) activators. Structure-activity relationship studies indicated that the nature and the stereochemistry of the substituent at the α-position of the head part containing the carboxyl group, the distance between the carboxyl group and the central benzene ring, the linking group between the central benzene ring and the distal benzene ring, and the substituent at the distal hydrophobic tail part of the molecule all play key roles in determining the potency and selectivity of PPAR subtype transactivation. This study has led to the identification of potent and human PPARα selective optically active α-alkylphenylpropanoic acid derivatives, which will be useful not only as pharmacological tools to investigate the physiology and pathophysiology of PPARα but also as candidate drugs for the treatment of altered metabolic homeostasis, such as dyslipidemia, obesity, and diabetes.",
author = "Masahiro Nomura and Takahiro Tanase and Tomohiro Ide and Masaki Tsunoda and Masahiro Suzuki and Hideharu Uchiki and Koji Murakami and Hiroyuki Miyachi",
year = "2003",
month = "8",
day = "14",
doi = "10.1021/jm0205144",
language = "English",
volume = "46",
pages = "3581--3599",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "17",

}

TY - JOUR

T1 - Design, synthesis, and evaluation of substituted phenylpropanoic acid derivatives as human peroxisome proliferator activated receptor activators. Discovery of potent and human peroxisome proliferator activated receptor α subtype-selective activators

AU - Nomura, Masahiro

AU - Tanase, Takahiro

AU - Ide, Tomohiro

AU - Tsunoda, Masaki

AU - Suzuki, Masahiro

AU - Uchiki, Hideharu

AU - Murakami, Koji

AU - Miyachi, Hiroyuki

PY - 2003/8/14

Y1 - 2003/8/14

N2 - Substituted phenylpropanoic acid derivatives were prepared as part of a search for subtype-selective human peroxisome proliferator activated receptor α (PPARα) activators. Structure-activity relationship studies indicated that the nature and the stereochemistry of the substituent at the α-position of the head part containing the carboxyl group, the distance between the carboxyl group and the central benzene ring, the linking group between the central benzene ring and the distal benzene ring, and the substituent at the distal hydrophobic tail part of the molecule all play key roles in determining the potency and selectivity of PPAR subtype transactivation. This study has led to the identification of potent and human PPARα selective optically active α-alkylphenylpropanoic acid derivatives, which will be useful not only as pharmacological tools to investigate the physiology and pathophysiology of PPARα but also as candidate drugs for the treatment of altered metabolic homeostasis, such as dyslipidemia, obesity, and diabetes.

AB - Substituted phenylpropanoic acid derivatives were prepared as part of a search for subtype-selective human peroxisome proliferator activated receptor α (PPARα) activators. Structure-activity relationship studies indicated that the nature and the stereochemistry of the substituent at the α-position of the head part containing the carboxyl group, the distance between the carboxyl group and the central benzene ring, the linking group between the central benzene ring and the distal benzene ring, and the substituent at the distal hydrophobic tail part of the molecule all play key roles in determining the potency and selectivity of PPAR subtype transactivation. This study has led to the identification of potent and human PPARα selective optically active α-alkylphenylpropanoic acid derivatives, which will be useful not only as pharmacological tools to investigate the physiology and pathophysiology of PPARα but also as candidate drugs for the treatment of altered metabolic homeostasis, such as dyslipidemia, obesity, and diabetes.

UR - http://www.scopus.com/inward/record.url?scp=0042732947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042732947&partnerID=8YFLogxK

U2 - 10.1021/jm0205144

DO - 10.1021/jm0205144

M3 - Article

C2 - 12904063

AN - SCOPUS:0042732947

VL - 46

SP - 3581

EP - 3599

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 17

ER -